Clinical Trial: Microencapsulated Sodium Propionate in IBD Microbiota Modulation

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883044) titled 'Microencapsulated Sodium Propionate in IBD Microbiota Modulation' on April 13.

Brief Summary: The goal of this clinical trial is to evaluate whether microencapsulated sodium propionate can modulate the gut microbiota and improve inflammatory and immunological parameters in adult patients with inflammatory bowel disease (IBD) in remission or with mild disease activity. The study will also compare its effects with those of sodium butyrate.

The main questions it aims to answer are:

* Does sodium propionate modify gut microbiota composition and metabolic pathways in patients with IBD?

* Does sodium propionate influence inflammatory m...